当前位置：
X-MOL 学术
›
Diabetes Care
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58.
Diabetes Care ( IF 16.2 ) Pub Date : 2022-02-01 , DOI: 10.2337/dc21-1668 Ahmed A Kolkailah 1 , Stephen D Wiviott 2 , Itamar Raz 3 , Sabina A Murphy 2 , Ofri Mosenzon 4 , Deepak L Bhatt 2 , Lawrence A Leiter 5 , John P H Wilding 6 , Ingrid Gause-Nilsson 7 , Marc S Sabatine 2 , Darren K McGuire 1, 8
中文翻译：
达格列净对心血管高危 2 型糖尿病患者血细胞比容的影响：来自 DECLARE-TIMI 58 的观察。
更新日期：2022-01-12
Diabetes Care ( IF 16.2 ) Pub Date : 2022-02-01 , DOI: 10.2337/dc21-1668 Ahmed A Kolkailah 1 , Stephen D Wiviott 2 , Itamar Raz 3 , Sabina A Murphy 2 , Ofri Mosenzon 4 , Deepak L Bhatt 2 , Lawrence A Leiter 5 , John P H Wilding 6 , Ingrid Gause-Nilsson 7 , Marc S Sabatine 2 , Darren K McGuire 1, 8
Affiliation
中文翻译：
达格列净对心血管高危 2 型糖尿病患者血细胞比容的影响：来自 DECLARE-TIMI 58 的观察。
京公网安备 11010802027423号